The Business Research Company adds a report “Anti-Infective Drugs Market By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs)), Opportunities And Strategies – Global Forecast To 2022” under its pharmaceuticals category. The report covers market characteristics, key players, market size and trends from 2014 to 2022.
The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites and antiprotozoal agents.
View Complete Report:
The anti-infective drugs market size is expected to grow at a growth rate of around 6% to nearly $116 billion by 2022.
Growth in the historic period resulted from the rise in incidence rate of infectious diseases, aging population and growth in emerging markets.
Going forward, the global economic growth and developments in drug discovery procedures will drive growth of the Anti-Infective Drugs industry. Factors that negatively affected growth in the historic period were patent expiration of drugs, pricing pressures from regulators, and low return on Investment in the anti-infective drugs industry. Factors that could hinder the growth of this market in the future are results of the global antimicrobial resistance, shortage of anti-infective drugs and reduction in free trade.
Request a Sample of This Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=smp
One of the anti-infective drugs trends is that anti-infective drug manufacturers are investing in programs to develop drugs to treat drug resistant infections. Antimicrobial resistance is a serious concern to global public health as it results in long duration of illness, the requirement of additional tests and use of more expensive drugs.
Some of the major drivers of the market are:
Economic Growth – The global economy is expected to go through a continued period of steady growth during the forecast period, thus positively impacting the growth of the anti-infective drugs market. Economic growth will result in a rise in income levels, increased access to healthcare facilities and investments in the pharmaceutical industry.
Developments In Drug Discovery Procedures – The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems.
However, the market is expected to face restraints from several factors such as –
Antimicrobial Resistance – The anti-infective drugs market is expected to be restrained by an increasing number of antimicrobial resistance cases due growing ineffectiveness of conventional anti-infective drugs such as penicillin. Antimicrobial resistance is the final stage of the adaptation process of microorganisms such as bacteria to the environment developing the ability to resist the effects of anti-infective drugs.
Avail the Discount provided on this report@ https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=discount
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info